"ANP32B" Related Products

Expand
Expand

Recombinant Human AIF1L protein, His-tagged

Cat.No.: AIF1L-3444H
Product Overview: Recombinant Human AIF1L(1-150aa) fused with His tag at N-terminal was expressed in E. coli.
Description: AIF1L, also known as allograft inflammatory factor 1-like, is a cytoplasmic, cytokine-induced, calcium-binding protein first discovered in rat cardiac allografts with chronic rejection. This protein is a marker of human microglia and is expressed by macrophages in injured skeletal muscle and regulates reduced proliferation and differentiation of satellite cells.
Source: E. coli
Species: Human
Tag: His
Form: Liquid. 20mM Tris-HCl buffer (pH8.0) containing 20% glycerol 0.1M NaCl, 1mM DTT
Molecular Mass: 19.2 kDa (170aa), confirmed by MALDI-TOF
AA Sequence: MGSSHHHHHH SSGLVPRGSHSLKRMMEKLG VPKTHLEMKK MISEVTGGVS DTISYRDFVN MMLGKRSAVL KLVMMFEGKA NESSPKPVGP PPERDIASLP MSGELSNRFQ GGKAFGLLKA RQERRLAEIN REFLCDQKYS DEENLPEKLT AFKEKYMEFD LNNEGEIDLM
Purity: >95% by SDS - PAGE
Storage: Can be stored at +4 centigrade short term (1-2 weeks). For long term storage, aliquot and store at -20 centigrade or -70 centigrade. Avoid repeated freezing and thawing cycles.
Concentration: 1.0 mg/ml (determined by BCA assay)
Gene Name: AIF1L allograft inflammatory factor 1-like [ Homo sapiens ]
Official Symbol: AIF1L
Synonyms: AIF1L; allograft inflammatory factor 1-like; C9orf58, chromosome 9 open reading frame 58; FLJ12783; IBA2; ionized calcium binding adapter molecule 2; ionized calcium-binding adapter molecule 2; C9orf58; MGC29466;
Gene ID: 83543
mRNA Refseq: NM_031426
Protein Refseq: NP_113614
MIM:
UniProt ID: Q9BQI0
Chromosome Location: 9q34.13-q34.3
Function: actin filament binding; calcium ion binding;

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.